Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chrissi Pallidis"'
Autor:
Mona Khurana, Gunter F. Egger, Lynne Yao, Aliza Thompson, Chrissi Pallidis, Stuart L. Goldstein, Benjamin L. Laskin, Shamir Tuchman, Meaghan A. Malley, Katrin Uhlig
Publikováno v:
Clinical Journal of the American Society of Nephrology.
Autor:
Nicholas M Croft, Lissy de Ridder, Anne M Griffiths, Jeffrey S Hyams, Frank M Ruemmele, Dan Turner, Katharine Cheng, Irja Lutsar, Marco Greco, Zuzanna Gołębiewska, Floriane Laumond, Maria Cavaller-Bellaubi, Adam Elgreey, Tara A Altepeter, Chrissi Pallidis, Koen Norga, Robert Nelson, Wallace Crandall, Gilles Vassal
Publikováno v:
Journal of Crohn's & colitis, 17(2), 249-258. Oxford University Press
Background and Aims Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two approved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2933fe299ef362ab1142f48b39899f72
https://pure.eur.nl/en/publications/557fd4fd-0e74-4060-9c04-8b295ed80eae
https://pure.eur.nl/en/publications/557fd4fd-0e74-4060-9c04-8b295ed80eae
Publikováno v:
Archives of Disease in Childhood. 103:557-564
IntroductionThis paper focuses on the authorisation of new medicines, new indications and new pharmaceutical forms or strengths for use in children and also on the availability of paediatric information in the product information of centrally authori
Publikováno v:
Pediatric Drugs. 19:505-513
The year 2017 marks the tenth anniversary of entry into force of the Paediatric Regulation in the European Union (EU). This law aimed to stimulate the development of paediatric medicines and provide more information on their use, as a response to the